leadf
logo-loader
viewInvitrocue Ltd

InvitroCue Ltd to develop novel assay to detect pancreatic toxicity

au_drug_research_358_578598590d8dd.jpg

Bio-analytics company InvitroCue Ltd (ASX:IVQ) will leverage its technology in modelling multi-organ toxicity by developing a novel assay to detect pancreatic toxicity.

The assay is part of a strategic collaboration with Switzerland’s InSphero AG, the world’s leading provider of assay-ready 3D microtissues for more predictive drug discovery and development.

The pancreatic toxicity assay is being developed to accelerate preclinical drug development and assessment of potential pancreatic toxicity associated with drug metabolism.

This builds on a previous agreement between InSphero and InvitroCue on in-vitro cell-based hepatotoxicity assay.

InvitroCue has already introduced a suite of disease-specific drug screening services related to non-alcoholic steatohepatitis, leishmaniasis and malaria.

In May, InvitroCue entered the oncology testing market for drugs to provide data points in selected solid tumours.

The company will use 3D cell-based technology to culture patient derived cancer cells in its laboratories for testing against a panel of approved drugs and new drug candidates.

InvitroCue’s technology may create a new market for personalised drug testing to improve individual treatment outcomes in selected solid tumours.

The company had $2 million cash at the end of the March 2016 quarter.


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.

Quick facts: Invitrocue Ltd

Price: - AUD

ASX:IVQ
Market: ASX
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Invitrocue Ltd named herein, including the promotion by the Company of Invitrocue Ltd in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read